로딩 중…
지수 로딩 중…
Geron Corporation
GERN· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$1.26+2.44%
2026-06-18
Price Chart
Geron Corporation-18.71%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $808M |
| Revenue | $196M |
| Net Income | $-70M |
| Total Assets | $534M |
| Net Assets | $229M |
| Value | |
| P/B | 3.53x |
| P/S | 4.12x |
| FCF Yield | -15.62% |
| Profitability | |
| ROE | -30.37% |
| ROA | -13.03% |
| Op. Margin | -19.05% |
| Revenue Growth | 30.89% |
| Financial Health | |
| Debt Ratio | 133.13% |
| Total Debt | $252M |
| FCF | $-126M |
| Cash | $71M |
| Current Ratio | 6.78x |
| Performance | |
| 1Y Return | -18.71% |
| 1M Return | 3.28% |
| From 52W High | -37.31% |
| 1Y MDD | -43.59% |
| Trading | |
| Volume | 19,565,179 shares |
| Trading Value | $25M |
| Per Share | |
| EPS | $-0.13 |
| BPS | $0.34 |